(READ) FDA issues death warning on new cancer drug approved through “accelerated” process
The FDA has issued a safety alert on Pepaxto, a cancer drug approved under an accelerated process to treat multiple myeloma. The drug is called melphalan flufenamide. According to the FDA, Pepaxto causes an increased risk of death. Read the […]
